Skip to main content

Table 1 Demographic, clinical and laboratory findings of all the included patients

From: Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach

Clinical characteristics

total(n = 216)

ACS (n = 138)

non ACS (n = 78)

P

DM(n,%)

66 (30.6)

51 (37.0)

15 (19.2)

0.007

Age

60.61

59.88

61.90

0.170

Gender

131 (60.6)

96 (69.6)

35 (44.9)

0.000

Hypertention(n,%)

130 (60.2)

85 (61.2)

45 (57.7)

0.574

Current smoker(n,%)

74 (34.3)

61 (44.2)

13 (16.7)

0.000

Alcohol status(n,%)

40 (18.5)

31 (22.5)

9 (11.5)

0.047

Presentation of ACS

    

 STEMI(n,%)

11 (5.09)

11 (7.97)

  

 NSTEMI(n,%)

25 (11.57)

25 (18.12)

  

 UAP(n,%)

102 (47.22)

102 (73.91)

  

BMI(kg/cm2)

26.59 ± 4.27

26.08 ± 3.80

27.51 ± 4.89

0.018

TG(mmol/L)

1.74 ± 0.98

1.84 ± 1.11

1.56 ± 0.69

0.020

TC(mmol/L)

4.21 ± 1.27

4.33 ± 1.15

3.99 ± 1.43

0.063

HDL-C(mmol/L)

1.16 ± 0.28

1.12 ± 0.26

1.23 ± 0.29

0.004

LDL-C(mmol/L)

2.41 ± 0.94

2.37 ± 0.98

2.47 ± 0.87

0.475

LPa(mmol/L)

62.48 ± 84.89

70.69 ± 98.11

47.97 ± 51.49

0.027

FBG(mmol/L)

6.66 ± 2.73

6.91 ± 3.01

6.23 ± 2.10

0.053

BNP(pg/mL)

84.62 ± 144.59

98.19 ± 163.72

60.63 ± 98.84

0.037

hs-CRP(mg/L)

3.00 ± 4.34

2.92 ± 3.77

3.13 ± 5.22

0.730

  1. Continuous variables are presented as mean value ± 1 SD, whereas categorical variables are presented as absolute and relative frequencies
  2. ACS, acute coronary syndrome; STEMI, ST-elevated myocardial infarction; NSTEMI, non ST-elevated myocardial infarction; UAP, unstable angina pectoris; DM, diabetes mellitus; BMI, body mass index; TG, Triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; LPa, lipoprotein a; FBG, fasting blood glucose; BNP, B-natriuretic peptide; hs-CRP, hypersensitive C-reactive protein